1968년 11월 1일부터 1971년 8월 31일까지 2년 10개월동안 산후유즙분비를 억제한 산모 228례를 대상으로 관찰하여 다음과 같은 결과를 얻었다. 1. 152례(66.6%)는 stilbesterol, 38례(16.7%)는 anovular, 그리고 38례(16.7%)는 estandron을 사용했으며 그중 세밀히 follow up된 예는 anovular를 사용한 34례 estandron을 사용한 25례 이었다. 2. 유산후즙분비를 억제한 산모의 빈도는 8.8%였다. 3. 산후유즙분비를 억제한 산모의 적응증은 산모의 자기편리상이 125례(54.8%)로 수위를 점하고 있으며 미숙아가 48례(21.0%), 자궁내태아사망이 16례(7.0%), 산모질 환이 12례(5.3%), 직장관계가 12례(5.3%), 영아사망이 8례(3.5%), 선천적기형이 7례(3.1%)였다. 4. 유방증상은 anovular를 사용하여 경했거나 전혀 없어던 례가 79.5%였으며 estandrondms 56.0% duTek. 5. 유방증상이 쇠퇴되는데 요하는 기간은 anovular가 estandron에 비하여 약간 빠른 경향을 보였다.

A clinical survey of suppression of postpartum lactation has been made on 228 nonnursing mothers out of 2,582 deliveries at the Department of Obstetrics and Gynecology, Korea General Hospital from Nov. 1, 1968 to Aug. 31, 1971. the clinical datas obtained were as follows; 1. Immediately postpartum, 152(66.6%) nonnursing mothers were given stilbes- terol tablets, 38 (16.7%) cases were given anovular tablets, and another 38 (16.7%) cases were given estandron intramuscularly. 2. The incidence of nonnursing mothers was 8.8%. 3. In indication, desired suppression of laction for their convenience was the most common. Its rate was 54.8% and others were as follows; Premature 21.0%, intrauterine fetal death 7.0%, maternal disease 5.3%, occupation 5.3%, neonatal death 3.5%, and congenital malformation 3.1%. 4. Breast symtoms were absent or mild in 27 of 34 cases(79.5%) used anovular tablets and in 14 of 25 cases(56.0%) used estandron injection. 5. Duration of subsidence of breast symtoms in cases used anovular tablets was shorter than cases used estandron injedtion.